In a pilot, Utah is testing use of AI for renewing drug prescriptions. Experts ask if it should be regulated as a medical device.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
Sarepta’s big gene therapy expansion; Inside Iambic’s AI cycle; Vertex, Lilly unveil new diabetes data; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]
News
STAT+: Pharmalittle: We’re reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an existing shot Click here to view original post Click Here to Publish/Feature Your […]
News
Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano
Highlights Clarity has signed a commercial-scale agreement with Nusano, Inc. (“Nusano”) for supply of copper-64 (Cu-64 or 64Cu) isotope. The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more […]
